Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aritra Gangopadhyay

Is Merck & Co. Stock Outperforming the S&P 500?

Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health pharmaceuticals across various areas, including Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, and other brands. Valued at a market cap of $297 billion, the company also provides veterinary pharmaceuticals, vaccines and health management solutions and services.

Companies with a market cap of $200 billion or more are typically referred to as “mega-cap stocks.” Jabil fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the general drug manufacturers industry.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.